Neo Cremar Co. Ltd
Neo Cremar Co., Ltd. manufactures and sells functional food ingredients and additives in South Korea and internationally. The company offers microbiome, functional carbohydrate, functional protein, solubilizable functional ingredients, organic, and other products. It also provides functional foods, plant-based meat and cultured meat, customized health functional food, and pharmaceuticals business… Read more
Neo Cremar Co. Ltd (311390) - Total Liabilities
Latest total liabilities as of September 2025: ₩40.82 Billion KRW
Based on the latest financial reports, Neo Cremar Co. Ltd (311390) has total liabilities worth ₩40.82 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Neo Cremar Co. Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Neo Cremar Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Neo Cremar Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Neo Cremar Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Security Bancorp Inc
PINK:SCYT
|
USA | $345.41 Million |
|
Fast Food Indonesia Tbk
JK:FAST
|
Indonesia | Rp4.12 Trillion |
|
OUTLOOK THERAPEUTICS INC
NASDAQ:OTLK
|
USA | $50.77 Trillion |
|
American Realty Investors Inc
NYSE:ARL
|
USA | $287.64 Million |
|
Arianne Phosphate Inc
OTCQX:DRRSF
|
USA | $46.27 Million |
|
Vortex Consolidated Bhd
KLSE:0060
|
Malaysia | RM63.53 Million |
|
Hyungji Elite
KO:093240
|
Korea | ₩92.21 Billion |
|
OnKure Therapeutics, Inc.
NASDAQ:OKUR
|
USA | $6.41 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Neo Cremar Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Neo Cremar Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Neo Cremar Co. Ltd (2016–2024)
The table below shows the annual total liabilities of Neo Cremar Co. Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩107.55 Billion | +233.23% |
| 2023-12-31 | ₩32.27 Billion | +8.92% |
| 2022-12-31 | ₩29.63 Billion | +204.99% |
| 2021-12-31 | ₩9.72 Billion | +2.16% |
| 2020-12-31 | ₩9.51 Billion | +0.05% |
| 2019-12-31 | ₩9.50 Billion | +4.03% |
| 2018-12-31 | ₩9.14 Billion | -45.92% |
| 2017-12-31 | ₩16.89 Billion | +333.10% |
| 2016-12-31 | ₩3.90 Billion | -- |